Fake FDA 'special agents' work drug scam

If an FDA official calls and tells you to pay a fine to someone in the Dominican Republic, don't wire the money. That's the agency's latest caution to consumers, prompted by a new scam: Con artists sell prescription drugs over the phone, but the drugs never arrive--and then a "FDA special agent" calls with the punishment. Release | Report 

Suggested Articles

Pfizer’s Ibrance has met with success in breast cancer since breaking onto the scene in 2015. But its first foray into early breast cancer was a bust.

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.